These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1737924

  • 1. The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock.
    Michalek MT, Benacerraf B, Rock KL.
    J Immunol; 1992 Feb 15; 148(4):1016-24. PubMed ID: 1737924
    [Abstract] [Full Text] [Related]

  • 2. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
    Kovacsovics-Bankowski M, Rock KL.
    Eur J Immunol; 1994 Oct 15; 24(10):2421-8. PubMed ID: 7925570
    [Abstract] [Full Text] [Related]

  • 3. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
    Adorini L, Guéry JC, Fuchs S, Ortiz-Navarrete V, Hämmerling GJ, Momburg F.
    J Immunol; 1993 Oct 01; 151(7):3576-86. PubMed ID: 7690807
    [Abstract] [Full Text] [Related]

  • 4. Weak base amines can inhibit class I MHC-restricted antigen presentation.
    Michalek MT, Benacerraf B, Rock KL.
    J Immunol; 1991 Jan 15; 146(2):449-56. PubMed ID: 1987272
    [Abstract] [Full Text] [Related]

  • 5. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M, Pfeifer J, Stockinger B, Wick MJ.
    Behring Inst Mitt; 1997 Feb 15; (98):197-211. PubMed ID: 9382741
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen.
    Rock KL, Rothstein L, Fleischacker C, Gamble S.
    J Immunol; 1992 May 15; 148(10):3028-33. PubMed ID: 1578128
    [Abstract] [Full Text] [Related]

  • 7. MHC class I-restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo.
    Grant EP, Rock KL.
    J Immunol; 1992 Jan 01; 148(1):13-8. PubMed ID: 1727862
    [Abstract] [Full Text] [Related]

  • 8. Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides.
    Hosken NA, Bevan MJ, Carbone FR.
    J Immunol; 1989 Feb 15; 142(4):1079-83. PubMed ID: 2492575
    [Abstract] [Full Text] [Related]

  • 9. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
    Martinez-Kinader B, Lipford GB, Wagner H, Heeg K.
    Immunology; 1995 Oct 15; 86(2):287-95. PubMed ID: 7490131
    [Abstract] [Full Text] [Related]

  • 10. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
    Kjer-Nielsen L, Perera JD, Boyd LF, Margulies DH, McCluskey J.
    J Immunol; 1990 Apr 15; 144(8):2915-24. PubMed ID: 1969876
    [Abstract] [Full Text] [Related]

  • 11. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells.
    Diebold SS, Cotten M, Koch N, Zenke M.
    Gene Ther; 2001 Mar 15; 8(6):487-93. PubMed ID: 11313828
    [Abstract] [Full Text] [Related]

  • 12. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation.
    Harding CV, Collins DS, Kanagawa O, Unanue ER.
    J Immunol; 1991 Nov 01; 147(9):2860-3. PubMed ID: 1918996
    [Abstract] [Full Text] [Related]

  • 13. Nonionic triblock copolymers facilitate delivery of exogenous proteins into the MHC class I and class II processing pathways.
    Ke Y, McGraw CL, Hunter RL, Kapp JA.
    Cell Immunol; 1997 Mar 15; 176(2):113-21. PubMed ID: 9073383
    [Abstract] [Full Text] [Related]

  • 14. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L, Ullrich SJ, Appella E, Fuchs S.
    Nature; 1990 Jul 05; 346(6279):63-6. PubMed ID: 2366863
    [Abstract] [Full Text] [Related]

  • 15. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S, Bertolino P, Deng H, Gerlier D, Rabourdin-Combe C.
    Immunology; 1993 Dec 05; 80(4):566-73. PubMed ID: 7508420
    [Abstract] [Full Text] [Related]

  • 16. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM, Rowell JF, Soloski MJ, Machamer CE, Siliciano RF.
    J Immunol; 1993 Sep 15; 151(6):2928-42. PubMed ID: 8376762
    [Abstract] [Full Text] [Related]

  • 17. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.
    St-Pierre Y, Watts TH.
    J Immunol; 1990 Aug 01; 145(3):812-8. PubMed ID: 2373860
    [Abstract] [Full Text] [Related]

  • 18. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules.
    Brazil MI, Weiss S, Stockinger B.
    Eur J Immunol; 1997 Jun 01; 27(6):1506-14. PubMed ID: 9209504
    [Abstract] [Full Text] [Related]

  • 19. Major histocompatibility complex non-restricted presentation to CD4+ T lymphocytes of Mycobacterium leprae heat-shock protein 65 antigen by macrophages transfected with the mycobacterial gene.
    Silva CL, Lukacs K, Lowrie DB.
    Immunology; 1993 Jan 01; 78(1):35-42. PubMed ID: 7679662
    [Abstract] [Full Text] [Related]

  • 20. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
    Moreno J, Vignali DA, Nadimi F, Fuchs S, Adorini L, Hämmerling GJ.
    J Immunol; 1991 Nov 15; 147(10):3306-13. PubMed ID: 1658143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.